Richard P. Baum is Director of the Advanced Theranostics Center for Radiomolecular Precision Oncology, Curanosticum at Deutsche Klinik für Diagnostik (DKD HELIOS Klinik), Wiesbaden, Germany. Professor Baum is also the President of the ICPO Academy, Chairman of the Scientific Board of the ICPO Foundation and previous President of WARMTH (World Association of Radiopharmaceutical and Molecular Therapy) and of the International Research Group on Immuno-Scintigraphy and Therapy (IRIST). He is the co-founder - together with Prof. Frank Rösch - of the Theranostics World Congress (TWC) in 2011.

Thomas Beyer holds a PhD in Physics and is co-developer of the first combined PET/CT system worldwide. He has a background in research and project management in academia and imaging industry.
Thomas graduated in Physics at the Leipzig University (Germany) and got his PhD in Medical Physics from Surrey University (UK). During his US-based studies he became involved in the development and clinical testing of the first PET/CT prototype (1992-2000) before joining Siemens/CTI PET Systems as an International PET/CT specialist. In 2002 he became a Research Associate in Nuclear Medicine and Radiology and PET/CT project manager at Essen University Hospital (Germany). In 2006 he became Teaching Professor (Priv-Doz) for Experimental Nuclear Medicine at Essen, and joined timaq medical imaging Inc, a Zurich-based Imaging CRO. In 2007 he moved to Philips Medical Systems as International Manager Clinical Science Nuclear Medicine. In 2008 he set up a Zurich-based consulting company for expert advise in cross-modality imaging and applications. He is appointed full professor of Physics of Medical Imaging at the Medical University of Vienna from March 2013.
Thomas is a member of various national and international Medicine organizations, a founding member of the European Association of Nuclear Medicine (EANM) Physics Committee and past Head of the New Technology working group at the Association of Imaging Producers and Equipment Suppliers (AIPES).

Prof. Paola Anna Erba is set to assume the role of EANM President in January 2025, following Rudi Dierckx’s tenure. She is an Associate Professor in Nuclear Medicine and Diagnostic Imaging at the Medical Faculty of Bicocca University, and Chair of the Nuclear Medicine Department at ASST Papa Giovanni XXIII in Bergamo. She is also affiliated with the Department of Nuclear Medicine and Molecular Imaging at the University Medical Center Groningen, the Netherlands. She was also the Vice Director of the Nuclear Medicine Residency Programme from 2016 to 2022.

Dr. Francesco Giammarile is a physician licensed in Italy and in France, with a post-graduate degree in nuclear medicine, a PhD in biophysics and MSc in oncology, pedagogy, hyperbaric medicine and nuclear physics. At present, he works as Senior Technical Officer for the International Atomic Energy Agency for the development of Nuclear Medicine in low to middle income countries. From 2006 to 2017, he was a professor in the nuclear medicine department of the university hospital in Lyon.

Professor Rod Hicks is the Founder, Chief Medical Officer, and Board Chair of Precision Molecular Imaging and Theranostics (PreMIT Pty Ltd.). He has been actively involved in advancing the field of nuclear medicine through being an innovator and pioneer in positron emission tomography (PET) and therapeutic use of radiopharmaceuticals for over 30 years. Professor Hicks was formerly the Director of Cancer Imaging at the Peter MacCallum Cancer Centre in Melbourne, where he built a world-renowned nuclear medicine service.

Josh is an internationally recognized advocate for neuroendocrine tumor patients as well as an advocate for integrative oncology, nuclear medicine, and molecular imaging. He is the inaugural chairman of the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) Patient Advocacy Advisory Board, a member of the Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF) Board and President of NorCal CarciNET Community. Mr. Mailman has an MBA from the Anderson School of Management at UCLA and has been a technology entrepreneur for more than 20 years.